These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 29103946

  • 1. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN, Novakovic TR, Markovic-Jovanovic SR, Smilic LLJ, Mitic JS, Radunovic ML.
    J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
    [Abstract] [Full Text] [Related]

  • 2. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [Abstract] [Full Text] [Related]

  • 3. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD.
    Blood Cells Mol Dis; 2014 Nov; 52(2-3):91-4. PubMed ID: 24091145
    [Abstract] [Full Text] [Related]

  • 4. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L.
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [Abstract] [Full Text] [Related]

  • 5. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 6. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K, Gut P, Sowińska A, Ruchała M, Fichna M.
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [Abstract] [Full Text] [Related]

  • 7. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K, Kristoffersson AO, Lorentzon RP.
    Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
    [Abstract] [Full Text] [Related]

  • 8. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 9. Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.
    Zhao X, Zhang XM, Yuan N, Yu XF, Ji LN.
    Exp Clin Endocrinol Diabetes; 2019 Jan; 127(1):50-55. PubMed ID: 30396213
    [Abstract] [Full Text] [Related]

  • 10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL.
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [Abstract] [Full Text] [Related]

  • 11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [Abstract] [Full Text] [Related]

  • 12. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 13. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR.
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [Abstract] [Full Text] [Related]

  • 14. Bone biomarkers in patients with chronic traumatic spinal cord injury.
    Sabour H, Norouzi Javidan A, Latifi S, Larijani B, Shidfar F, Vafa MR, Heshmat R, Emami Razavi H.
    Spine J; 2014 Jul 01; 14(7):1132-8. PubMed ID: 24139865
    [Abstract] [Full Text] [Related]

  • 15. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z, Jin X, Bian P, Li X, Chen J.
    Geriatr Gerontol Int; 2017 May 01; 17(5):773-778. PubMed ID: 27137883
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate.
    Yavropoulou MP, Hamdy NA, Papapoulos SE.
    Osteoporos Int; 2013 Aug 01; 24(8):2353-7. PubMed ID: 23436076
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
    Perksanusak T, Panyakhamlerd K, Hirankarn N, Suwan A, Vasuratna A, Taechakraichana N.
    Climacteric; 2018 Dec 01; 21(6):581-585. PubMed ID: 30232913
    [Abstract] [Full Text] [Related]

  • 19. Changes in bone mass and bone turnover following tibial shaft fracture.
    Veitch SW, Findlay SC, Hamer AJ, Blumsohn A, Eastell R, Ingle BM.
    Osteoporos Int; 2006 Dec 01; 17(3):364-72. PubMed ID: 16362144
    [Abstract] [Full Text] [Related]

  • 20. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women.
    Ting BL, Walley KC, Travison TG, Rozental TD.
    J Hand Surg Am; 2017 Feb 01; 42(2):71-77. PubMed ID: 28160903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.